Diajard-MXR 25mg/1000mg for Type 2 Diabetes
Diajard-MXR 25mg/1000mg Tablet is the highest-strength fixed-dose combination of empagliflozin 25mg (SGLT2 inhibitor) and metformin 1000mg extended release for adults with type 2 diabetes needing maximal HbA1c reduction from once-daily dual therapy. The XR formulation improves metformin tolerability. A prescription is required for this medication. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, dehydration, or when unable to eat — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue. May increase risk of genital yeast infections and urinary tract infections. May cause dizziness — sit or stand up slowly. Take with food to reduce stomach upset.
Pay in 3 Installments of
Rs.
101
Diajard-mxr 25mg/1000mg for Type 2 Diabetes
Description
Diajard-MXR Tablets 25mg/1000mg – Extended-Release Dual Action Diabetes Therapy
Diajard-MXR Tablets 25mg/1000mg are a prescription oral antidiabetic medication used for the management of type 2 diabetes mellitus in adults. This advanced dual-combination therapy contains empagliflozin and metformin extended-release, offering effective and long-lasting blood sugar control for patients requiring stronger glycemic management.
Empagliflozin lowers blood glucose levels by increasing the elimination of excess glucose through the kidneys, while metformin XR works over an extended period to reduce glucose production in the liver and improve insulin sensitivity. This complementary mechanism helps maintain stable blood sugar levels throughout the day, controlling both fasting and post-meal glucose spikes.
Diajard-MXR 25mg/1000mg is particularly suitable for patients who require higher-dose empagliflozin along with extended-release metformin for improved tolerability and once-daily convenience. When combined with a healthy diet and regular physical activity, it supports long-term diabetes control and helps reduce the risk of diabetes-related complications.
This medication should be used strictly under medical supervision. Regular monitoring of blood glucose levels is recommended to ensure safe and effective treatment.
How to Order Diajard-MXR 25mg/1000mg at Derma.pk
At Derma.pk, we ensure the authenticity of Diajard-MXR Tablets 25mg/1000mg, verified by licensed pharmacists. Delivery is available across Pakistan. For prescriptions or inquiries, contact sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
Maximum combined strength: highest empagliflozin dose plus full metformin XR in one tablet
Once-daily extended-release formulation for simplified, well-tolerated dosing
Cardiovascular protection: empagliflozin reduces heart failure hospitalisation and CKD progression
Stronger HbA1c reduction for patients who did not achieve target on lower-strength combinations
Low intrinsic hypoglycaemia risk — neither component forces insulin release
Smoother extended-release metformin profile reduces peak-related gastrointestinal discomfort
How To Use
Take one Diajard-MXR 25mg/1000mg tablet once daily with the evening meal. Take with food to reduce stomach upset. Swallow whole — do not crush, cut, or chew. An inert shell may appear in your stool — this is normal and expected for XR tablets. Do not stop without consulting your doctor. Sick-day rule: temporarily stop during severe illness, vomiting, diarrhoea, dehydration, before contrast imaging, or before surgery — consult your doctor immediately. Risk of euglycaemic diabetic ketoacidosis (DKA): seek emergency care if you experience persistent nausea, vomiting, abdominal pain, or unusual fatigue — even when blood sugar appears normal. May increase risk of genital yeast infections and urinary tract infections. May cause dizziness — sit or stand up slowly. Stay hydrated. Avoid heavy alcohol. Monitor HbA1c, eGFR, and vitamin B12 periodically.
FAQs
Who is prescribed Diajard-MXR 25mg/1000mg?
This top-strength combination is used when patients with type 2 diabetes need maximal HbA1c reduction and have not achieved adequate control on lower-strength SGLT2 and metformin combinations.
Why was the 25mg empagliflozin dose chosen?
The higher 25mg dose provides greater urinary glucose elimination than 10mg. It is selected when 10mg provided insufficient glycaemic response, as decided by your doctor.
What sick-day rules apply to this combination?
Temporarily stop during vomiting, diarrhoea, fever, dehydration, fasting, before contrast-dye imaging, or before surgery. Both DKA (from empagliflozin) and lactic acidosis (from metformin) risks are elevated — consult your doctor immediately.
What DKA warning signs require emergency care?
Seek emergency care immediately for persistent nausea, vomiting, abdominal pain, fruity-smelling breath, or unusual fatigue — even if blood sugar reads normal. This is euglycaemic DKA linked to SGLT2 inhibitors.
What is the eGFR limit for this medication?
Diajard-MXR 25/1000 is contraindicated below eGFR 45 mL/min. Kidney function should be monitored periodically throughout treatment.



